revis
definit
sepsi
lifethreaten
organ
dysfunct
caus
dysregul
host
respons
infect
object
studi
evalu
procalcitonin
pct
diagnosi
prognosi
sepsi
use
enrol
patient
admit
emerg
depart
suspect
bacteri
infect
june
februari
definit
bacteri
infect
defin
proven
cultur
result
probabl
bacteri
infect
base
diagnost
modal
cultur
sequenti
organ
failur
assess
sofa
score
point
baselin
diagnos
sepsi
pct
measur
immunoassay
system
boditech
med
inc
use
whole
blood
white
blood
cell
wbc
creactiv
protein
crp
erythrocyt
sediment
rate
er
evalu
final
diagnosi
sepsi
patient
infect
respiratori
genitourinari
tract
constitut
area
receiv
oper
characterist
curv
auroc
confid
interv
ci
follow
pct
crp
esr
wbc
respect
multivari
analysi
age
sofa
pct
log
scale
predict
nonsurvivor
odd
ratio
confid
interv
respect
among
sepsi
group
initi
pct
increas
nonsurvivor
ngdl
compar
survivor
group
ngdl
statist
signific
p
conclus
pct
could
support
predict
unfavor
prognosi
sepsi
base
wherea
diagnost
potenti
pct
requir
evalu
bacteremia
diagnosi
procalcitonin
prognosi
sepsi
origin
concept
sepsi
defin
system
inflammatori
respons
syndrom
sir
document
microbi
infect
use
two
decad
definit
revis
part
due
improv
understand
pathobiolog
sepsi
sepsi
regard
earli
activ
proand
antiinflammatori
respons
involv
nonimmunolog
system
includ
cardiovascular
endocrin
coagul
addit
low
diagnost
capabl
sir
led
revis
definit
sepsi
though
sir
criteria
might
still
use
identif
infect
revis
definit
sepsi
propos
lifethreaten
organ
dysfunct
caus
dysregul
host
respons
infect
brief
former
condit
sepsi
sever
sepsi
regard
bacteri
infect
sepsi
respect
revis
definit
emphas
organ
dysfunct
calcul
sequenti
organ
failur
assess
sofa
score
sofa
scorebas
definit
sepsi
predict
mortal
higher
sirsbas
definit
infect
lead
organ
failur
patient
infect
care
follow
eas
applic
clinic
environ
laboratori
data
includ
sofa
score
bilirubin
creatinin
platelet
count
continu
attempt
diagnosi
sir
sepsi
sever
sepsi
use
biomark
especi
procalcitonin
pct
creactiv
protein
crp
white
blood
cell
wbc
erythrocyt
sediment
rate
esr
variou
interleukin
pct
biomark
debat
use
clinic
applic
previou
literatur
reveal
pct
could
support
clinic
diagnosi
treatment
patient
among
biomark
pct
crp
includ
diagnost
criteria
inflammatori
variabl
surviv
sepsi
campaign
howev
surviv
sepsi
campaign
pct
revis
recommend
biomark
sepsi
prognosi
diagnosi
diagnosi
prognosi
import
sepsi
sever
biomark
includ
pct
presepsin
cytokin
studi
predict
prognosi
former
definit
sepsi
addit
pct
relat
antimicrobi
stewardship
treatment
encompass
initi
taper
antimicrobi
treatment
biomark
evalu
previous
defin
sever
sepsi
might
reflect
perform
revis
sepsi
due
differ
detail
definit
addit
diagnosi
sepsi
revis
su
sofa
score
requir
three
clinic
variabl
three
laboratori
variabl
lead
score
rang
zero
hypothes
pct
crp
wbc
esr
might
result
capabl
diagnos
sepsi
reflect
prognosi
diagnost
capabl
biomark
could
evalu
area
receiv
oper
characterist
curv
auroc
valu
prognost
capabl
biomark
could
evalu
univari
multivari
analysi
therefor
studi
evalu
access
biomark
includ
pct
crp
esr
wbc
clinic
set
util
diagnosi
prognosi
revis
sepsi
singlecent
studi
perform
tertiari
teach
hospit
studi
protocol
approv
institut
review
board
incheon
st
mari
hospit
individu
consent
requir
institut
review
board
data
obtain
cours
diagnosi
treatment
among
enrol
patient
data
follow
compon
sofa
score
collect
grade
pao
fio
mm
hg
platelet
count
bilirubin
glasgow
coma
scale
gc
score
creatinin
renal
output
level
mean
arteri
pressur
mean
arteri
pressur
calcul
follow
diastol
blood
pressur
systol
blood
pressur
diastol
blood
pressur
enrol
patient
suspect
bacteri
infect
sofa
score
point
baselin
diagnos
sepsi
routin
microbiolog
examin
includ
two
pair
blood
cultur
sampl
cultur
use
two
set
aerob
anaerob
bottl
bactec
plu
bactec
autom
blood
cultur
system
bd
bioscienc
use
incub
day
cultur
analysi
variou
bodi
fluid
urin
sputum
bronchoalveolar
lavag
fluid
cerebrospin
fluid
abscess
close
wound
perform
blood
sampl
wbc
count
esr
pct
crp
blood
chemistri
drawn
immedi
present
emerg
depart
analyz
central
laboratori
within
hour
hematolog
paramet
includ
wbc
measur
sysmex
sysmex
highsensit
creactiv
protein
crp
withinlaboratori
respect
tabl
limit
blank
limit
detect
provid
manufactur
ngml
claim
analyt
measur
rang
ngml
ngml
cutoff
valu
provid
manufactur
ngml
cohort
consist
patient
diagnos
suspect
bacteri
infect
initi
admit
emerg
depart
patient
classifi
nonsepsi
group
sepsi
group
tabl
show
comparison
demograph
baselin
data
nonsepsi
group
sepsi
group
mean
age
pct
wbc
patient
sepsi
group
significantli
higher
patient
nonsepsi
group
identifi
bacteria
microorgan
list
detail
tabl
among
identifi
microb
escherichia
coli
common
pathogen
follow
klebsiella
speci
staphylococcu
aureu
roc
curv
pct
crp
esr
level
wbc
count
diagnosi
sepsi
shown
figur
among
age
sex
biomark
age
pct
wbc
sofa
score
reveal
statist
signific
univari
analysi
tabl
variabl
multivari
analysi
perform
among
age
sofa
score
pct
log
scale
predict
nonsurvivor
statist
signific
multivari
analysi
tabl
comparison
survivor
n
nonsurvivor
n
perform
among
sepsi
group
tabl
pct
higher
nonsurvivor
group
compar
survivor
group
among
test
marker
pct
reveal
statist
signific
p
hemoglobin
lower
nonsurvivor
group
sofa
score
compon
reveal
statist
signific
except
platelet
bilirubin
sever
sepsi
reveal
higher
sensit
specif
respect
compar
sofa
qsofa
sir
criteria
might
use
earlier
sign
infect
develop
organ
dysfunct
diagnosi
sepsi
depend
sofa
score
revis
sepsi
definit
includ
immun
dysregul
requir
measur
cytokin
suspect
relat
immun
dysregul
exact
pathobiolog
must
identifi
cytokin
immuneregul
molecul
complex
network
analysi
might
reveal
pathobiolog
network
analysi
reveal
sepsi
network
small
size
path
length
short
might
reflect
immun
dysregul
pct
one
molecul
hub
node
among
sepsi
network
impli
pct
expect
play
import
role
among
cytokin
network
sepsi
interact
molecul
limit
studi
approxim
patient
diagnos
respiratori
tract
genitourinari
tract
infect
might
differ
condit
hospit
intens
care
unit
emerg
depart
age
increas
sepsi
group
age
one
prognost
factor
predict
unfavor
prognosi
singlecent
studi
patient
popul
might
affect
preval
sepsi
group
conclus
revis
definit
sepsi
pct
could
support
prognosi
sepsi
predict
mortal
compar
paramet
studi
requir
accumul
data
pct
use
revis
sepsi
definit
patient
diagnosi
manag
thank
emerg
depart
laboratori
depart
staff
support
studi
thank
sungyeon
lee
chankyu
kim
se
woon
cho
excel
technic
assist
dong
wook
jekarl
http
